ZCM
SNDX icon

Ziegler Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Ziegler Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,090
Closed -$361K – 423
2023
Q1 		$361K Sell
17,090
-16,597
-49% -$413K 0.01% 369
2022
Q4 		$857K Sell
33,687
-7,926
-19% -$185K 0.04% 303
2022
Q3 		$1M Sell
41,613
-244
-0.6% -$5.47K 0.04% 295
2022
Q2 		$805K Buy
+41,857
New +$697K 0.03% 324

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ziegler Capital Management's SNDX Position: Q2 2023 in Review

Ziegler Capital Management sold out of Syndax Pharmaceuticals (SNDX) in Q2 2023, closing a stake of 17,090 shares — an estimated $361K sold.

Ziegler Capital Management first reported a position in SNDX in Q2 2022 and held it in 4 quarters. The position peaked at $1M in Q3 2022. 166 funds tracked by Wall St. Rank hold SNDX as of Q2 2023.

  • Ziegler Capital Management reported no remaining Syndax Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Ziegler Capital Management sold 17,090 Syndax Pharmaceuticals shares in Q2 2023, an estimated $361K.
  • Ziegler Capital Management first reported a position in Syndax Pharmaceuticals in Q2 2022 and held it in 4 quarters.
  • Ziegler Capital Management's Syndax Pharmaceuticals position peaked at $1M in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2023.

Based on Ziegler Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.